project id: TCGA-HNSC; case submitter id: TCGA-BA-A4II; source center: 23; state: released; a260 a280 ratio: 1.9; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.54; rna integrity number: 8.4; age at index: 46; days to birth: -17011; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1965; age at diagnosis: 17011; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage I; ajcc clinical t: T1; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 918.0; icd 10 code: C10.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Oropharynx, NOS; synchronous malignancy: Yes; tissue or organ of origin: Oropharynx, NOS; tumor grade: Not Reported; year of diagnosis: 2011; treatment or therapy: no; alcohol history: Yes; cigarettes per day: 1.36986301369863; pack years smoked: 25.0; is ffpe: false; composition: Not Reported; initial weight: 190.0; oct embedded: false; preservation method: Unknown; sample id: 81bbc439-0c8c-4d39-bef2-03901b31c50e; sample submitter id: TCGA-BA-A4II-01A; portion id: 38ddf7ab-d08e-44a1-93a3-29edba7d18b7; portion submitter id: TCGA-BA-A4II-01A-11; slide id: 51d64a85-c5b7-4f78-9d57-d79a00e3632d; slide submitter id: TCGA-BA-A4II-01A-01-TS1; percent lymphocyte infiltration: 25.0; percent monocyte infiltration: 2.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 60.0; percent tumor cells: 40.0; percent tumor nuclei: 80.0; section location: TOP;